Anti-Acetaminophen polyclonal antibody

Aspirin (ASA) exerts an anti-tumor effect via the COX pathway. Clinical studies on the chemopreventive effects of ASA on uterine cancer (UC) remain inconsistent. We used population-based retrospective cohort study to evaluate the UC in ASA users in Taiwanese women. From insurance claims data, we identified 23,342 women received ASA treatment between 2000 and 2010 and a comparison group of same sample size randomly selected from the same database matched by the propensity score. The incidence of UC in the ASA cohort was 10% of that in the comparison group (0.28 vs 2.73 per 10,000 person-years). The Poisson regression analysis estimated adjusted incidence rate ratio (IRR) was 0.10 (95% confidence interval (CI) = 0.09-0.11) for ASA users relatives to comparisons after controlling for covariates. The UC incidence in ASA users decreased with age, from 0.61 per 10,000 person-years in the 20 to 39 years old (adjusted IRR = 0.21, 95% CI = 0.15-0.29) to 0.21 per 10,000 person-years in the 65 to 80 years old (adjusted IRR = 0.15, 95% CI = 0.12-0.16). The incidence was higher in longer term users. Hormone therapy of estradiol was associated with the increase of UC risk in both cohorts, but less in ASA users than comparisons (1.34 vs 4.75 per 10,000 person-years). This study suggests that ASA use was associated with a decreased risk of UC. Further prospective randomized clinical trials are warranted to confirm the association.

Herein, a novel electrochemical sensor based on ZIF-67/MWCNT-COOH/Nafion composite was designed and prepared for simultaneous detection of 4-aminophenol (4-AP) and acetaminophen (AMP). The electrochemical behaviors of the 4-AP and AMP on the ZIF-67/MWCNT-COOH/Nafion electrode were explored via cyclic voltammetry (CV) and differential pulse voltammetry (DPV). The results exhibited that the designed electrochemical sensor possessed superior electrocatalytic activity for 4-AP and AMP, which was attributed to the highly ordered porous structure of ZIF-67, the outstanding electrical conductivity and high electrocatalytic activity of MWCNT-COOH. Under optimization conditions, the DPV response of the prepared electrode depicted a wider linear response concentration range of 0.2 to 200 mu M for 4-AP, and 0.1 to 100 mu M for AMP, respectively. And the lower detection limits (LOD) of 0.01 and 0.07 mu M were obtained for 4-AP and AMP, respectively. More importantly, the acquired electrode was applied to Yellow river water and Paracetamol tablets for analysis of 4-AP and AMP, which exhibited satisfying recovery of 98.2% similar to 106.7% for 4-AP and 94.7% similar to 99.6% for AMP, respectively. In a word, the constructed electrochemical sensing platform delivered a promising potential in real application.